These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 16846397)

  • 1. Prevalence of hypogonadism in males aged at least 45 years: the HIM study.
    Mulligan T; Frick MF; Zuraw QC; Stemhagen A; McWhirter C
    Int J Clin Pract; 2006 Jul; 60(7):762-9. PubMed ID: 16846397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does early morning versus late morning draw time influence apparent testosterone concentration in men aged > or =45 years? Data from the Hypogonadism In Males study.
    Guay A; Miller MG; McWhirter CL
    Int J Impot Res; 2008; 20(2):162-7. PubMed ID: 17637790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.
    Kapoor D; Aldred H; Clark S; Channer KS; Jones TH
    Diabetes Care; 2007 Apr; 30(4):911-7. PubMed ID: 17392552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
    Morgentaler A; Rhoden EL
    Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study.
    Schneider HJ; Sievers C; Klotsche J; Böhler S; Pittrow D; Lehnert H; Wittchen HU; Stalla GK
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):446-54. PubMed ID: 18691272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction.
    Makhlouf AA; Mohamed MA; Seftel AD; Niederberger C
    Int J Impot Res; 2008; 20(2):157-61. PubMed ID: 17703222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of androgen deficiency in men with erectile dysfunction.
    Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
    Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses.
    Guay A; Seftel AD; Traish A
    Int J Impot Res; 2010; 22(1):9-19. PubMed ID: 19798059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction.
    Bunch TJ; Abraham D; Wang S; Meikle AW
    Aging Male; 2002 Mar; 5(1):38-46. PubMed ID: 12040974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and influence of diagnostic criteria in the assessment of hypogonadism in intrathecal opioid therapy patients.
    Duarte RV; Raphael JH; Labib M; Southall JL; Ashford RL
    Pain Physician; 2013 Jan; 16(1):9-14. PubMed ID: 23340538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
    Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
    Moisey R; Swinburne J; Orme S
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
    Ogbera OA; Sonny C; Olufemi F; Wale A
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadism in men with chronic pain linked to the use of long-acting rather than short-acting opioids.
    Rubinstein AL; Carpenter DM; Minkoff JR
    Clin J Pain; 2013 Oct; 29(10):840-5. PubMed ID: 24384986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadism and diabetes.
    Betancourt-Albrecht M; Cunningham GR
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S14-20. PubMed ID: 12934046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
    Sarosdy MF
    Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadism.
    Citron JT; Ettinger B; Rubinoff H; Ettinger VM; Minkoff J; Hom F; Kan P; Alloo R
    J Urol; 1996 Feb; 155(2):529-33. PubMed ID: 8558653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.